These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 828260)

  • 21. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2005 Oct; 251(1):19-22. PubMed ID: 16143463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of kanamycin and isoniazid on the sensitivity of Mycobacterium tuberculosis to the defensive factors of the macroorganism].
    Solov'ev VN; Sokolova EM; Chumachenko NV
    Probl Tuberk; 1965; 43(10):69-72. PubMed ID: 4959763
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of rifampicin action on mycobacterial cells. Consideration to the potentiation problem of antimycobacterial treatment.
    Trnka L
    Acta Tuberc Pneumol Belg; 1969; 60(3):356-65. PubMed ID: 4984419
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of infection with Mycobacterium tuberculosis and BCG on the lactic dehydrogenase and succinic dehydrogenase activity of guinea pig liver.
    Kwiek S; Wyszomirska J; Rzucidlo L
    Acta Microbiol Pol; 1967; 16(4):297-301. PubMed ID: 4170604
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical significance of the degree of resistance of tubercular mycobacteria to specific chemoantibiotics (clinical note)].
    Lucchesi M; Mancini P; Sbampato M
    Ann Ist Carlo Forlanini; 1968; 28(1):74-90. PubMed ID: 4985828
    [No Abstract]   [Full Text] [Related]  

  • 26. KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates.
    Goto M; Oka S; Tachikawa N; Kitada K; Wada M; Abe C; Shimada K; Kimura S
    Mol Cell Probes; 1995 Dec; 9(6):433-9. PubMed ID: 8808314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mycobacterium tuberculosis resistant drugs and their effect on guinea pigs inoculated with a mixture of sensitive and resistant M. tuberculosis].
    Belogurova VP
    Antibiotiki; 1971 May; 16(5):429-33. PubMed ID: 5002222
    [No Abstract]   [Full Text] [Related]  

  • 29. Vitamin B 12 synthesis by Mycobacteria. II. Isoniazid resistance & vitamin B 12 activity of Mycobacterium tuberculosis H37Rv.
    Aithal HN; Sirsi M
    Indian J Biochem; 1964 Sep; 1(3):166-7. PubMed ID: 4243420
    [No Abstract]   [Full Text] [Related]  

  • 30. [A rapid susceptibility test of Mycobacterium tuberculosis using hybridization protection assay].
    Miyamoto J; Koga H; Kohno S; Ohno H; Fukuda M; Ogawa K; Tomono K; Kaku M; Hara K; Hashimoto A
    Kekkaku; 1995 Jun; 70(6):377-83. PubMed ID: 7630073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of emerging isoniazid resistance to Mycobacterium tuberculosis in Korea.
    Hong YP; Jin BW; Kim SJ
    Aviat Space Environ Med; 1988 Feb; 59(2):185. PubMed ID: 3125824
    [No Abstract]   [Full Text] [Related]  

  • 32. [Catalase activity of drug-resistant Mycobacterium tuberculosis strains].
    Smirnov VD
    Antibiotiki; 1971 Oct; 16(10):917-9. PubMed ID: 5003057
    [No Abstract]   [Full Text] [Related]  

  • 33. [Streptomycin and isoniazid resistance of strains of Mycobacterium tuberculosis isolated in Catania].
    Placenti A
    Lotta Tuberc; 1969; 39(4):264-74. PubMed ID: 4997375
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of hypoglycemic drugs on results of treatment with nicotinic acid hydrazide in experimental tuberculosis in guinea pigs, caused by Mycobacterium tuberculosis of low resistance to INH].
    Kulig A
    Patol Pol; 1968; 19(1):237-41. PubMed ID: 4968014
    [No Abstract]   [Full Text] [Related]  

  • 35. [Incidence and significance of positive fluorescent bacilloscopy associated with negative cultures during treatment based on isoniazid or rifomycin in tubercular patients treated in the sanatorium].
    Augier J; Parrot R; Gillet P
    Acta Tuberc Pneumol Belg; 1969; 60(3):417-29. PubMed ID: 4984422
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 37. Transmission of isoniazid-resistant tuberculosis.
    Borgdorff MW
    J Infect Dis; 2004 Aug; 190(3):650; author reply 650-1. PubMed ID: 15243944
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical significance of resistance of Mycobacterium tuberculosis to chemoantibiotics].
    Lucchesi M; Zubiani M; Mancini P; Termine A
    Ann Ist Carlo Forlanini; 1967; 27(3):228-52. PubMed ID: 4972422
    [No Abstract]   [Full Text] [Related]  

  • 39. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM; Utkin VV; Fedorova IE; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):355-7. PubMed ID: 4993044
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG.
    Ghiladi RA; Medzihradszky KF; Rusnak FM; Ortiz de Montellano PR
    J Am Chem Soc; 2005 Sep; 127(38):13428-42. PubMed ID: 16173777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.